
CJC-1295 DAC
Extended-half-life GHRH analog
Extended-half-life GHRH analog featuring Drug Affinity Complex for sustained growth hormone modulation research.
The DAC modification extends the half-life of CJC-1295 by binding to serum albumin. The result is sustained GHRH activity relevant for endocrinology research on growth hormone secretion patterns, age-related GH insufficiency, and longer-cycle metabolic studies.
For research use only.
Intended strictly for in-vitro research and laboratory use. Not for human consumption. Not evaluated by the FDA. No statements on this page are intended to diagnose, treat, cure, or prevent any disease.


